TABLE 1.
Population characteristics of asymptomatic participants with rK39-positive and VL patients.
| Cohort | Subject type (n) | Sex % female (n) | Age in years (95% CI) | Body mass index (95% CI) | Hemoglobin g/dl (95% CI) |
| Asymptomatic | with subsequent VL (16) | 44 (7) | 14.78 (8.13–21.44) | 15.70 (14.34–17.05) | 12.53 (11.26–13.80) |
| without subsequent VL (15) | 47 (7) | 15.94 (14.34–17.05) | 15.94 (14.40–17.47) | 12.80 (11.57–14.11) | |
| p-value between groups | 0.56 | 0.90 | 0.80 | 0.71 | |
| VL patients | Treatment failure (7) | 14.3 (1) | 114.9 (5.0–224.7) | 13.6 (11.9–15.3) | 7.8# (6.5–9.1) |
| VL relapse (10) | 50.0 (5) | 169.2 (74.1–264.3) | 14.1 (11.6–16.5) | 10.1 (8.8–11.4) | |
| Post-kala-azar Dermal Leishmaniasis (32) | 37.5 (12) | 247.1 (184.3–309.9) | 15.3 (14.2–16.3) | 9.3 (8.7–10.0) | |
| VL control (38) | 34.2 (13) | 231.5 (175.9–287.1) | 15.2 (14.4–16.0) | 10.1# (9.5–10.6) | |
| p-value between groups | 0.49 | 0.21 | 0.16 | 0.82 |
#p = 0.008.